24/7 Wall St. » MFLX

Media Digest 11/9/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

247wallst — Mon, 09 Nov 2009 09:03:01 +0000

Reuters: Hurricane Ida is heading toward Gulf oil fields.

Reuters: Kraft (NYSE:KFT) will make its bid for Cadbury.

Reuters: GE (NYSE:GE) and Comcast (NASDAQ:CMCSA) have agreed to an NBCU valuation.

Reuters: The IMF is considering an insurance levy on banks.

Reuters: Opel unions want autonomy as a condition for talks.

Reuters: Advanta filed for bankruptcy protection.

Reuters: Morgan Stanley (NYSE:MS) will try to sell its stake in China bank CICC.

Reuters: Sprint (NYSE:S) will invest more in Clearwire (NASDAQ:CLWR).

Reuters: China said it hopes the US will keep its deficit at an “appropriate” size.

Reuters: The head of Goldman Sachs (NYSE:GS) said banks do “God’s work.”

WSJ: Companies that sell to consumers say that the customers will be frugal for a long time.

WSJ: G20 officials disagreed on a tax on bank transactions.

WSJ: NBCU will be valued at $30 billion.

WSJ: AXA AsiaPacific rejected at $10 billion bid from AMP.

WSJ: Northrup Grumman (NYSE:NOC) will sell its TASC unit for $1.7 billion.

WSJ: A healthcare bill would cause wide oversight of insurance companies.

WSJ: Dollar General is about to go public.

WSJ: Microsoft (NASDAQ:MSFT) Windows 7 sales are off to a strong start.

WSJ: S&P has begun considering offering potential loss numbers from some residential bonds.

WSJ: Public company stock listings have dropped sharply in recent years.

WSJ: Las Vegas Sands (NYSE:LVS) hopes to raise $3.83 billion in the IPO of its Asia unit.

WSJ: Some of the largest banks do not provide adequate data about investment banks and securities operations.

WSJ: Wal-Mart (NYSE:WMT) risks little in its e-book and DVD prices wars because online sales are only 1% of revenue

WSJ: The Supreme Court will decide when a business when a business method can be patented

WSJ: Lear is set to exit Chapter 11 as a smaller car parts firm

NYT: Rent the Runway wants to do for fashion what NetFlix (NASDAQ:NFLX) did for movies.

NYT: Circulation at The New York Post, owned by News Corp (NYSE:NWS) is down about 30% in a little over two years.

NYT: Wal-Mart (NYSE:WMT) is working on a program to help people who run out of money at the end of a month.

NYT: The strength of the US economy is overstated because of the way imports are accounted for in measures of gross domestic product and worker productivity.

NYT: The number of Twitter tweets a day rose to 26 million a day in October from 2.4 million in January.

FT: The markets’ inflation readings are moving up.

FT: Long-dated oil prices have risen to within a whisker of $100 a barrel.

FT: News Corp is paying $1 million a month for empty MySpace offices

FT: Robot hamster toys are popular for Christmas.

Douglas A. McIntyre

Posted in Press Digest Tagged: CLWR, CMCSA, GE, GS, KFT, LVS, MFLX, MS, MSFT, NOC, NWS, S, WMT

Top Pre-Market Analyst Upgrades (AER, AGU, CF, GVA, MFLX, OMRI, PM, PFG, TRA)

247wallst — Tue, 04 Nov 2008 07:40:11 +0000

These are some the top pre-market upgrades from analysts we have seen with more than two hours until the market opens this Tuesday morning:

AerCap (AER) Raised to Buy at Citigroup.
Agrium (AGU) Raised to Buy at Citigroup.
CF Industries (CF) Raised to Buy at Citigroup.
Granite Construction (GVA) Raised to Neutral at Goldman Sachs.
Multi-Fineline Electronix (MFLX) Raised to Buy at Needham.
Omrix Biopharma (OMRI) Raised to Buy at UBS.
Philip Morris International (PM) Raised to Outperform at Credit Suisse.
Principal Financial (PFG) Raised to Market Perform at FBR.
Terra Industries (TRA) Raised to Buy at Citigroup.

Jon C. Ogg
November 3, 2008

Posted in Analyst Calls Tagged: AER, AGU, CF, GVA, MFLX, OMRI, PFG, PM, TRA

Top 10 Pre-Market Analyst Calls (ADBE, CRUS, DVA, EEQ, EQR, IP, LNCR, RGLD, WIN, BRL, MFLX, MYL, TEVA, WPI)

247wallst — Tue, 18 Dec 2007 07:59:00 +0000

These are not the only analyst impact calls, but these are the top research notes that 247WallSt.com is focusing on:

Adobe Systems (ADBE) raised to Buy at Deutsche Bank.
Cirrus Logic (CRUS) raised to Buy at Jefferies.
DaVita (DVA) raised to Buy at Oppenheimer.
Embarq (EQ) raised to Overweight at J.P.Morgan.
Equity Residential (EQR) raised to Overweight at Lehman.
International Paper (IP) raised to Outperform at Credit Suisse.
Lincare (LNCR) downgraded to Neutral at Oppenheimer.
Royal Gold (RGLD) raised to Overweight at HSBC.
Windstream (WIN) downgraded to Underweight at J.P.Morgan.
BANC OF AMERICA ON DRUGS: Barr Pharma (BRL) started as Buy; Multi-Fineline (MFLX) started as Buy; Mylan Labs (MYL) started as Buy; Teva Pharma (TEVA) started as Buy; Watson Pharma (WPI) started as neutral; ZymoGenetics (ZGEN) downgraded to Neutral.

Jon C. Ogg
December 18, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.

Pre-Market Stock News (July 12, 2007)

247wallst — Thu, 12 Jul 2007 07:07:25 +0000

(AA) Alcoa trading up 6% after Rio Tinto gave a higher rival bid over Alcoa’s buyout offer for Alcan.
(AAON) AAON announced a 3 for 2 stock split.
(AL) Alcan gets a rival $38.1 Billion bid from Rio Tinto, above the ALCOA bid; shares up 11%.
(AMGN) Amgen and Daiichi Sankyo announced a collaboration and license agreement for the development and commercialization of denosumab in Japan.
(ARIA) Ariad Pharm and Merck entered into a collaboration to jointly develop and commercialize AP23573 for use in cancer.
(DNA) Genentech $0.78 EPS ($0.70 after items) and revenues were $3.0 Billion versus $0.71 & $2.85 Billion estimates; sees Fiscal 2007 EPS $2.85 to $2.95 versus $2.91 estimates.
(EROC) Eagle Rock is making 3 acquisitions totaling $420 million; sees 48% increase in "distributable cash flow."
(FAST) Fastenal announced a 1 million share buyback plan.
(GE) General Electric and Abbott Labs terminate sale of Abbott’s lab and diagnostics unit.
(GGBM) Gigabeam has regained compliance standards for NASDAQ listing.
(GTXI) GTX’s Phase III development of Acapodene review by an independent Data Safety Monitoring Board recommended that GTX continue clinical development.
(HAL) Halliburton’s board of directors approved its increased $2 Billion share buyback plan.
(IMCL) Imclone and Bristol-Myers Squibb said Erbitux Phase III study in first-line treatment of advanced lung cancer did not meet its primary endpoint of progression-free survival but secondary endpoints were statistically significant and favored the ERBITUX- containing arm.
(MAR) Marriott $0.57 EPS vs $0.53e; but Q3 looks under estimates.
(METH) Methode Electronics $0.33 EPS vs $0.17e; unsure if comparable as guidance range is in-line.
(MFLX) Multi-Fineline saw an unexpected sequential decline in Q3 revenue and now expects a loss.
(MOT) Motorola lowered guidance and sees no more profit from mobile division in 2007.
(NEM) Newmont Mining priced a $1 Billion convertible note offering.
(SPNC) Spectranetics received FDA approval for expanded labeling for TURBO elite to market its TURBO elite laser catheters to treat stenoses and occlusions within leg arteries.
(WMT) Wal-Mart June s-s-s +2.4% vs. 0.8% estimate; sees 1% to 2% July s-s-s growth; sees fiscal 2008 EPS within previous $0.75 to $0.79 guidance; shares indicated up 0.6%.
(WFMI) Whole Foods CEO Mackey has been touting his stock and attacking rival Wild oats for years on Yahoo! message boards.

Jon C. Ogg
July 12, 2007